Sign In

Login

Password

Forgot Password ? Sign Up

Υπερχοληστερολαιμία (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Υπερχοληστερολαιμία" in Greek language version.

refsWebsite
Global rank Greek rank
26nih.gov
4th place
4th place
8doi.org
2nd place
3rd place
2consumerreports.org
4,720th place
5,470th place
2web.archive.org
1st place
1st place
1worldcat.org
5th place
8th place

consumerreports.org

doi.org

dx.doi.org

  • Durrington, P (August 2003). «Dyslipidaemia». The Lancet 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. 
  • Biggerstaff KD, Wooten JS (December 2004). «Understanding lipoproteins as transporters of cholesterol and other lipids». Adv Physiol Educ 28 (1–4): 105–6. doi:10.1152/advan.00048.2003. PMID 15319192. 
  • Carmena R, Duriez P, Fruchart JC (June 2004). «Atherogenic lipoprotein particles in atherosclerosis». Circulation 109 (23 Suppl 1): III2–7. doi:10.1161/01.CIR.0000131511.50734.44. PMID 15198959. 
  • Kontush A, Chapman MJ (March 2006). «Antiatherogenic small, dense HDL--guardian angel of the arterial wall?». Nat Clin Pract Cardiovasc Med 3 (3): 144–53. doi:10.1038/ncpcardio0500. PMID 16505860. 
  • Hooper L, Summerbell CD, Thompson R, et al. (2012). Hooper, Lee, επιμ. «Reduced or modified dietary fat for preventing cardiovascular disease». Cochrane Database Syst Rev 5: CD002137. doi:10.1002/14651858.CD002137.pub3. PMID 22592684. 
  • Ito MK, McGowan MP, Moriarty PM (June 2011). «Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia». J Clin Lipidol 5 (3 Suppl): S38–45. doi:10.1016/j.jacl.2011.04.001. PMID 21600528. 
  • Consumer Reports; Drug Effectiveness Review Project (March 2013). Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price. Consumer Reports, σελ. 9. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf. Ανακτήθηκε στις 27 March 2013  , που παραπέμπει στο Grundy, Scott M.; Cleeman, James I.; Merz, C. Noel Bairey; Brewer, H. Bryan; Clark, Luther T.; Hunninghake, Donald B.; Pasternak, Richard C.; Smith, Sidney C. και άλλοι. (2004-07-13). «Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines». Circulation 110 (2): 227–239. doi:10.1161/01.CIR.0000133317.49796.0E. ISSN 1524-4539. PMID 15249516. https://www.ncbi.nlm.nih.gov/pubmed/15249516. 
  • Mach, François; Baigent, Colin; Catapano, Alberico L; Koskinas, Konstantinos C; Casula, Manuela; Badimon, Lina; Chapman, M John; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Richter, Dimitrios J; Sabatine, Marc S; Taskinen, Marja-Riitta; Tokgozoglu, Lale; Wiklund, Olov; Mueller, Christian; Drexel, Heinz; Aboyans, Victor; Corsini, Alberto; Doehner, Wolfram; Farnier, Michel; Gigante, Bruna; Kayikcioglu, Meral; Krstacic, Goran; Lambrinou, Ekaterini; Lewis, Basil S; Masip, Josep; Moulin, Philippe; Petersen, Steffen; Petronio, Anna Sonia; Piepoli, Massimo Francesco; Pintó, Xavier; Räber, Lorenz; Ray, Kausik K; Reiner, Željko; Riesen, Walter F; Roffi, Marco; Schmid, Jean-Paul; Shlyakhto, Evgeny; Simpson, Iain A; Stroes, Erik; Sudano, Isabella; Tselepis, Alexandros D; Viigimaa, Margus; Vindis, Cecile; Vonbank, Alexander; Vrablik, Michal; Vrsalovic, Mislav; Zamorano, José Luis; Collet, Jean-Philippe; Koskinas, Konstantinos C; Casula, Manuela; Badimon, Lina; John Chapman, M; De Backer, Guy G; Delgado, Victoria; Ference, Brian A; Graham, Ian M; Halliday, Alison; Landmesser, Ulf; Mihaylova, Borislava; Pedersen, Terje R; Riccardi, Gabriele; Richter, Dimitrios J; Sabatine, Marc S; Taskinen, Marja-Riitta; Tokgozoglu, Lale; Wiklund, Olov; Windecker, Stephan; Aboyans, Victor; Baigent, Colin; Collet, Jean-Philippe; Dean, Veronica; Delgado, Victoria; Fitzsimons, Donna; Gale, Chris P; Grobbee, Diederick; Halvorsen, Sigrun; Hindricks, Gerhard; Iung, Bernard; Jüni, Peter; Katus, Hugo A; Landmesser, Ulf; Leclercq, Christophe; Lettino, Maddalena; Lewis, Basil S; Merkely, Bela; Mueller, Christian; Petersen, Steffen; Petronio, Anna Sonia; Richter, Dimitrios J; Roffi, Marco; Shlyakhto, Evgeny; Simpson, Iain A; Sousa-Uva, Miguel; Touyz, Rhian M; Nibouche, Djamaleddine; Zelveian, Parounak H; Siostrzonek, Peter; Najafov, Ruslan; van de Borne, Philippe; Pojskic, Belma; Postadzhiyan, Arman; Kypris, Lambros; Špinar, Jindřich; Larsen, Mogens Lytken; Eldin, Hesham Salah; Viigimaa, Margus; Strandberg, Timo E; Ferrières, Jean; Agladze, Rusudan; Laufs, Ulrich; Rallidis, Loukianos; Bajnok, László; Gudjónsson, Thorbjörn; Maher, Vincent; Henkin, Yaakov; Gulizia, Michele Massimo; Mussagaliyeva, Aisulu; Bajraktari, Gani; Kerimkulova, Alina; Latkovskis, Gustavs; Hamoui, Omar; Slapikas, Rimvydas; Visser, Laurent; Dingli, Philip; Ivanov, Victoria; Boskovic, Aneta; Nazzi, Mbarek; Visseren, Frank; Mitevska, Irena; Retterstøl, Kjetil; Jankowski, Piotr; Fontes-Carvalho, Ricardo; Gaita, Dan; Ezhov, Marat; Foscoli, Marina; Giga, Vojislav; Pella, Daniel; Fras, Zlatko; de Isla, Leopoldo Perez; Hagström, Emil; Lehmann, Roger; Abid, Leila; Ozdogan, Oner; Mitchenko, Olena; Patel, Riyaz S (31 Αυγούστου 2019). «2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk». European Heart Journal 41 (1): 111–188. doi:10.1093/eurheartj/ehz455. 

nih.gov

ncbi.nlm.nih.gov

  • Durrington, P (August 2003). «Dyslipidaemia». The Lancet 362 (9385): 717–31. doi:10.1016/S0140-6736(03)14234-1. PMID 12957096. 
  • Biggerstaff KD, Wooten JS (December 2004). «Understanding lipoproteins as transporters of cholesterol and other lipids». Adv Physiol Educ 28 (1–4): 105–6. doi:10.1152/advan.00048.2003. PMID 15319192. 
  • Carmena R, Duriez P, Fruchart JC (June 2004). «Atherogenic lipoprotein particles in atherosclerosis». Circulation 109 (23 Suppl 1): III2–7. doi:10.1161/01.CIR.0000131511.50734.44. PMID 15198959. 
  • Kontush A, Chapman MJ (March 2006). «Antiatherogenic small, dense HDL--guardian angel of the arterial wall?». Nat Clin Pract Cardiovasc Med 3 (3): 144–53. doi:10.1038/ncpcardio0500. PMID 16505860. 
  • Hooper L, Summerbell CD, Thompson R, et al. (2012). Hooper, Lee, επιμ. «Reduced or modified dietary fat for preventing cardiovascular disease». Cochrane Database Syst Rev 5: CD002137. doi:10.1002/14651858.CD002137.pub3. PMID 22592684. 
  • Ito MK, McGowan MP, Moriarty PM (June 2011). «Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia». J Clin Lipidol 5 (3 Suppl): S38–45. doi:10.1016/j.jacl.2011.04.001. PMID 21600528. 
  • Consumer Reports; Drug Effectiveness Review Project (March 2013). Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price. Consumer Reports, σελ. 9. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf. Ανακτήθηκε στις 27 March 2013  , που παραπέμπει στο Grundy, Scott M.; Cleeman, James I.; Merz, C. Noel Bairey; Brewer, H. Bryan; Clark, Luther T.; Hunninghake, Donald B.; Pasternak, Richard C.; Smith, Sidney C. και άλλοι. (2004-07-13). «Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines». Circulation 110 (2): 227–239. doi:10.1161/01.CIR.0000133317.49796.0E. ISSN 1524-4539. PMID 15249516. https://www.ncbi.nlm.nih.gov/pubmed/15249516. 
  • ^ Genest, J; Frohlich, J, Fodor, G, McPherson, R, Working Group on Hypercholesterolemia and Other, Dyslipidemias (2003-10-28). "Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update". Canadian Medical Association Journal 169 (9): 921–4. PMC 219626. PMID 14581310.
  • ^ National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel, III) (2002-12-17). "Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report". Circulation 106 (25): 3143–421. PMID 12485966.
  • ^ Spector, R; Snapinn, SM (2011). "Statins for secondary prevention of cardiovascular disease: the right dose". Pharmacology 87 (1–2): 63–9. doi:10.1159/000322999. PMID 21228612.
  • ^ Pignone, M (2005). "Primary prevention: dyslipidaemia". Clin Evid (14): 142–50. PMID 16620402. Retrieved 2010-11-04.
  • ^ Gami, A (2006). "Secondary prevention of ischaemic cardiac events". Clin Evid (15): 195–228. PMID 16973010. Retrieved 2010-11-04.
  • ^ Jump up to: a b c d e f g h i Bhatnagar D, Soran H, Durrington PN (2008). "Hypercholesterolaemia and its management". BMJ 337: a993. doi:10.1136/bmj.a993. PMID 18719012.
  • ^ Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA (1998). "Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects". BMJ 316 (7139): 1213–20. doi:10.1136/bmj.316.7139.1213. PMC 28525. PMID 9552999. Retrieved 2010-11-04.
  • ^ Jump up to: a b Tonelli, M; Lloyd, A, Clement, F, Conly, J, Husereau, D, Hemmelgarn, B, Klarenbach, S, McAlister, FA, Wiebe, N, Manns, B, for the Alberta Kidney Disease, Network (2011-11-08). "Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis". CMAJ : Canadian Medical Association 183 (16): E1189–E1202. doi:10.1503/cmaj.101280. PMC 3216447. PMID 21989464.
  • ^ Jump up to: a b Ray et al; Seshasai, S. R. K.; Erqou, S.; Sever, P.; Jukema, J. W.; Ford, I.; Sattar, N. (2010). "Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants". Arch Intern Med 170 (12): 1024–31. doi:10.1001/archinternmed.2010.182. PMID 20585067. Retrieved 2010-11-04.
  • ^ Mills, EJ; Wu, P, Chong, G, Ghement, I, Singh, S, Akl, EA, Eyawo, O, Guyatt, G, Berwanger, O, Briel, M (2011 Feb). "Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials". QJM : monthly journal of the Association of Physicians 104 (2): 109–24. doi:10.1093/qjmed/hcq165. PMID 20934984.
  • ^ Jump up to: a b Taylor F, Ward K, Moore TH, et al. (2011). "Statins for the primary prevention of cardiovascular disease". In Taylor, Fiona. Cochrane Database Syst Rev (1): CD004816. doi:10.1002/14651858.CD004816.pub4. PMID 21249663.
  • ^ Lebenthal Y, Horvath A, Dziechciarz P, Szajewska H, Shamir R (2010). "Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials". Arch Dis Child 95 (9): 673–80. doi:10.1136/adc.2008.157024. PMID 20515970.
  • ^ Vijan, S; Hayward, RA; American College Of, Physicians (2004). "Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians". Ann Intern Med 140 (8): 650–8. doi:10.1059/0003-4819-140-8-200404200-00013. PMID 15096337. Retrieved 2010-11-04.
  • ^ Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines". J Am Coll Cardiol 44 (3): 720–32. doi:10.1016/j.jacc.2004.07.001. PMID 15358046.
  • ^ Hayward, RA; Hofer, TP; Vijan, S (2006). "Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem". Ann Intern Med 145 (7): 520–30. doi:10.7326/0003-4819-145-7-200610030-00010. PMID 17015870.
  • ^ Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (February 2009). "Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake". J Nutr 139 (2): 271–84. doi:10.3945/jn.108.095125. PMID 19091798.
  • ^ Weingärtner O. et al; Bohm, M.; Laufs, U. (2009). "Controversial role of plant sterol esters in the management of hypercholesterolaemia". European Heart Journal 30 (4): 404–9. doi:10.1093/eurheartj/ehn580. PMC 2642922. PMID 19158117.

nhlbi.nih.gov

  • Consumer Reports; Drug Effectiveness Review Project (March 2013). «Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price». Best Buy Drugs (Consumer Reports): 9. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf. Ανακτήθηκε στις 27 March 2013 , which cites
    • United States Department of Health and Human Services· National Heart, Lung, and Blood Institute· National Institutes of Health (Ιουνίου 2005). «NHLBI, High Blood Cholesterol: What You Need to Know». nhlbi.nih.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Απριλίου 2013. Ανακτήθηκε στις 27 Μαρτίου 2013. CS1 maint: Πολλαπλές ονομασίες: authors list (link)

    nccam.nih.gov

web.archive.org

  • Consumer Reports; Drug Effectiveness Review Project (March 2013). «Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price». Best Buy Drugs (Consumer Reports): 9. http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf. Ανακτήθηκε στις 27 March 2013 , which cites
    • United States Department of Health and Human Services· National Heart, Lung, and Blood Institute· National Institutes of Health (Ιουνίου 2005). «NHLBI, High Blood Cholesterol: What You Need to Know». nhlbi.nih.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 1 Απριλίου 2013. Ανακτήθηκε στις 27 Μαρτίου 2013. CS1 maint: Πολλαπλές ονομασίες: authors list (link)
    • ^ Barnes PM, Powell-Griner E, McFann K, Nahin RL (May 27, 2004). "Complementary and Alternative Medicine Use Among Adults: United States, 2002" (PDF). Advance Data from Vital and Health Statistics. http://nccam.nih.gov/news/2004/052704.htm Αρχειοθετήθηκε 2010-05-27 στο Wayback Machine. (343): 6–9. Retrieved 2010-11-04.

worldcat.org